Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M Luke Timmerman 11/20/09 Boston
Vertex Turns $109M Debt Into Stock Luke Timmerman 11/10/09 Boston
ISB Nabs $8M for Cancer Genome Luke Timmerman 11/10/09 Seattle
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters Luke Timmerman 11/10/09 Seattle
Helicos Takes Itself Off Block Luke Timmerman 11/09/09 Boston
Dendreon Burns $28M in Q3 Luke Timmerman 11/09/09 Seattle
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment Luke Timmerman 11/05/09 Seattle
SonoSite Sales Drop 13% Luke Timmerman 10/27/09 Seattle
Omeros, Worst Performing IPO of 2009, Casts Shadow Over Other Aspiring Biotechs Luke Timmerman 10/27/09 Seattle
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle Luke Timmerman 10/09/09 San Diego
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day Luke Timmerman 10/08/09 Seattle
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten Luke Timmerman 10/08/09 Boston
Omeros Raises $68.2M in Washington’s First IPO in Two Years Luke Timmerman 10/08/09 Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News Luke Timmerman 10/08/09 Seattle
Geospiza Wins NIH Cancer Grant Luke Timmerman 10/07/09 Seattle
Omeros Made Errors on NIH Grant, But Feds Accepted Internal Investigation Saying They Weren’t Overbilled Luke Timmerman 10/05/09 Seattle
Hutch Pulls In $40M From Stimulus Luke Timmerman 10/05/09 Seattle
Ironwood Recruits Genentech, Facebook Star as Company Knocks on Wall Street Doors Luke Timmerman 10/05/09 Boston
UW Gets $25M For Genome Center Luke Timmerman 10/02/09 Seattle
Teranode Gets $900K Debt Deal Luke Timmerman 10/02/09 Seattle
The San Diego Biotech Survival Index: Local Firms Make Strong Rebound In First Half of 2009 Luke Timmerman 09/23/09 San Diego
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 Luke Timmerman 09/22/09 Seattle
Calypso Medical Raises $50M to Strengthen Pinpointed Radiation Therapy for Cancer Luke Timmerman 09/17/09 Seattle
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News Luke Timmerman 09/17/09 Seattle
Omeros Moves Closer To IPO, Sets Price Goal Luke Timmerman 09/16/09 Seattle
State Hands Out $5.1M Biotech Grants Luke Timmerman 09/15/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say Luke Timmerman 08/26/09 Seattle
AVI Nails Down $30M Luke Timmerman 08/20/09 Seattle
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News Luke Timmerman 08/20/09 Seattle
Page 1 of 4 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.